| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |